Abraxis BioScience to Create Abraxis Health - Pioneering Personalized Medicine

Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated, global biotechnology company, announced that the Board of Directors has approved a strategic plan to create Abraxis Health, Inc., an independent, stand-alone company to be spun-off from Abraxis BioScience that will be dedicated to becoming a fully integrated, next-generation, evidence-based, personalized healthcare company.

"The opportunity that lies in front of Abraxis BioScience is enormous and is a result of the validated science underlying the company's proprietary nab(R) technology in the clinical setting," said Patrick Soon-Shiong, M.D., Chairman and Chief Executive Officer of Abraxis BioScience.

"In 2009, we plan to initiate nine pivotal registrational trials in multiple tumor types, including breast cancer, lung, melanoma and pancreatic cancers. In addition, Abraxis has initiated 65 investigator-sponsored Phase 2 studies and 16 Phase 1 studies. Together with the current approval of ABRAXANE in 36 countries and the continuing need to establish infrastructure for the global launch of this compound, the immense and exciting task that lies ahead should be the primary focus of Abraxis BioScience."

Abraxis BioScience will be solely dedicated to building its ABRAXANE franchise on a global basis, advancing an extensive Phase 3 clinical program, and leveraging its proprietary nab(R) technology platform. For the nine months ended September 30, 2008, Abraxis reported revenue from sales of ABRAXANE of $245.8 million.


(Editor compiled and published Abraxis BioScience to Create Abraxis Health - Pioneering Personalized Medicine at HealthNewsTrack on January 20, 2009 sourced from Abraxis BioScience - http://www.abraxisbio.com/)

Healthcare - recent articles and current news stories:

- iPads increase doctors efficiency in healthcare
- Emergency department visita are lower among most satisfied patients
- Surgeons age linked to safe health care
- 35 new drugs approved in 2011 in US
- Bollywood actress Juhi Chawla to build hospital for needy children

Most related articles:

- Abraxis BioScience to Create Abraxis Health - Pioneering Personalized Medicine
- Breast cancer drug Abraxane promising for malignant melanoma treatment - 13.8
- Creating personalized biomarkers from tumor DNA to treat cancer - 5.3
- Milnacipran for management of fibromyalgia approved - 4.1
- Nanotechnology offers new cancer breakthrough hope - 2.7

More related articles:

- Health, Personalized Medicine, Biotechnology, Healthcare, Breast cancer, Melanoma, Pancreatic cancer, Health profession
- Breast cancer drug Abraxane promising for malignant melanoma treatment - 10.5
- Early detection methods for pancreatic cancer urgently needed - 9.2
- Pancreatic cancer risk reduced by diabetes drug metformin - 8.6
- Obesity increases pancreatic cancer risk - 8.3

Healthcare related articles:

- GE and Intel to form healthcare alliance - 2.6
- H1N1 vaccination to include all patients in Pennsylvania, US - 2.6
- Cleveland Clinic, Google to enhance patients' healthcare experience - 2.3
- Blair Underwood to Kick off AHF's US HIV Testing Caravan - 2.1
- Two New Reports on Health Care Quality, US - 2.1

Healthcare article/news source:

Read more health articles from Abraxis BioScience and health articles from USA.

Healthcare - search related terms:

Biotechnology, Breast cancer, Health, Health profession, Healthcare, Melanoma, Pancreatic cancer, Personalized Medicine,
Healthcare books,

Searched keywords: Abraxis Health (30), Abraxis healthcare (11),

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
3.61